What is she best known for?
The fields of study she is best known for:
- Psychiatry
- Internal medicine
- Schizophrenia
Dorien H. Nieman mainly focuses on Psychiatry, Psychosis, Schizophrenia, Risk factor and Cognition.
Her research in Psychiatry intersects with topics in Internal medicine, Proportional hazards model, Clinical psychology and Hazard ratio.
Dorien H. Nieman works mostly in the field of Psychosis, limiting it down to concerns involving Developmental psychology and, occasionally, Audiology.
Her work carried out in the field of Schizophrenia brings together such families of science as First episode, Mental health and Prospective cohort study.
Her Risk factor research incorporates elements of Intervention, Relative risk, Psychological intervention and Antipsychotic.
Her work carried out in the field of Cognition brings together such families of science as Anhedonia, Intention-to-treat analysis, Psychopathology, Confidence interval and Number needed to treat.
Her most cited work include:
- Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification (238 citations)
- The Validity of the 16-Item Version of the Prodromal Questionnaire (PQ-16) to Screen for Ultra High Risk of Developing Psychosis in the General Help-Seeking Population (165 citations)
- Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. (160 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Psychosis, Psychiatry, Clinical psychology, Schizophrenia and Ultra high risk.
Her Psychosis study incorporates themes from Audiology, Young adult, Psychopathology, First episode and Risk factor.
As a part of the same scientific family, Dorien H. Nieman mostly works in the field of Young adult, focusing on Proportional hazards model and, on occasion, Prospective cohort study.
Her At risk mental state, Cognitive behavioral therapy, Neuropsychology, Cognition and Cannabis study are her primary interests in Psychiatry.
Her Clinical psychology research incorporates themes from Psychological intervention, Intervention, Anxiety, Mental health and Depression.
Her studies in Schizophrenia integrate themes in fields like Meta-analysis, Neurocognitive and Cohort.
She most often published in these fields:
- Psychosis (66.67%)
- Psychiatry (57.72%)
- Clinical psychology (30.08%)
What were the highlights of her more recent work (between 2018-2021)?
- Psychosis (66.67%)
- Clinical psychology (30.08%)
- Schizophrenia (30.08%)
In recent papers she was focusing on the following fields of study:
Dorien H. Nieman focuses on Psychosis, Clinical psychology, Schizophrenia, Psychiatry and Psychopathology.
The Ultra high risk research Dorien H. Nieman does as part of her general Psychosis study is frequently linked to other disciplines of science, such as Immigration, therefore creating a link between diverse domains of science.
Her Clinical psychology study combines topics in areas such as Psychological intervention, Mental health and Psychological resilience.
Her Schizophrenia research includes elements of Major depressive disorder, Neurocognitive, Cognition and Hazard ratio.
Her study on Antidepressant and Early intervention in psychosis is often connected to Risk assessment and Suicidal ideation as part of broader study in Psychiatry.
Her Psychopathology research is multidisciplinary, incorporating perspectives in Clinical trial and Montgomery–Åsberg Depression Rating Scale.
Between 2018 and 2021, her most popular works were:
- Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention (55 citations)
- European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP) (18 citations)
- The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis (17 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Schizophrenia
Her scientific interests lie mostly in Psychological intervention, Clinical psychology, Schizophrenia, Eicosapentaenoic acid and Docosahexaenoic acid.
Her Psychological intervention study results in a more complete grasp of Psychiatry.
Her research on Clinical psychology focuses in particular on Psychopathology.
Her research links Psychosis with Schizophrenia.
Her study in the field of Prodrome also crosses realms of Schizophreniform disorder.
Her work in Randomized controlled trial tackles topics such as Confidence interval which are related to areas like At risk mental state, Intensive care medicine, Meta-analysis and Stage.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
